Company / Operating Cash Flow
Chemed Corp. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$388.3M
FY2025
5-year range
$308.6M / $417.5M
FY2021-FY2025
Trend
-7.0%
vs FY2024
Sector context
#58 of 158
Health Care
What the data says
At $388M, Chemed Corp.'s operating cash flow ranks #58 of 158 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $135M in FY2016 to $489M in FY2020.
Based on SEC 10-K filings.
$388M in FY2025 with a 5-year CAGR of -4.5%.
Improved from $330M to $388M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
#58 of 158 in Health CareTop 37% of 158This company $388.3M Sector average $1.0B
▼
-62.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.5%, indicating a declining trend.
- In FY2025, operating cash flow decreased 7.0% year-over-year.
- Ranks #58 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $388.3M | -7.0% |
| FY2024 | $417.5M | +26.4% |
| FY2023 | $330.3M | +6.6% |
| FY2022 | $309.9M | +0.4% |
| FY2021 | $308.6M | -36.9% |
| FY2020 | $489.3M | +62.4% |
| FY2019 | $301.2M | +4.9% |
| FY2018 | $287.1M | +76.7% |
| FY2017 | $162.5M | +20.0% |
| FY2016 | $135.4M | -21.1% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026